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Abstract

Shingles, the disease caused by the herpes zoster virus, is a widespread and widely
misunderstood illness in the United States. It is preventable, but many at-risk patients do
not know what measures they may take to prevent it. Clear communication from
physician to patient is crucial for patient understanding of diseases. Many patient
education materials on herpes zoster currently available are often unused. It is therefore
beneficial to public health to disseminate new mediums of medical communication, and
one way of accomplishing this is through adult coloring books. The pathophysiology of
herpes zoster virus is here explored and the idea of using an adult coloring book to
educate patients on the subject in a comprehensible way is presented.
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Herpes Zoster Patient Education: A Coloring Book Approach
Herpes zoster (HZ), more commonly called shingles, results from the reactivation
of varicella zoster virus (VZV), which initially causes chicken pox. Shingles affects
sensory nerve ganglia and peripheral nerves and their branches and produces intense pain
in patients having a shingles outbreak. Annually, 1.1 million cases of HZ occur in the
U.S., and despite the availability of an HZ vaccine, a low vaccination rate is a public
health concern. Many unvaccinated participants in a clinical study were unaware that the
vaccine is available and recommended (Teeter et al, 2014). Despite HZ being common,
many patients have misconceptions about the pathophysiology of the disease and
treatment options, which include oral antiviral medications (Reeves & Beuscher, 2015).
According to Simberkoff, The herpes zoster vaccine is both safe and well
tolerated in older, immunocompetent adults. Recipients may receive some localized side
effects, but no risk has been found for infection of HZ occurring from the inoculation.
Furthermore, it appears not to lead to any more serious health complications. Since
evidence supports the benefits of routine vaccinations for the at-risk population, new and
more effective strategies for spreading public awareness about shingles and its prevention
are needed (Simberkoff et al., 2010).
According to Williams, Davis, Parker, and Weiss, Public awareness of medical
issues such as HZ is vitally dependent upon the concept of patient health literacy. Patient
health literacy is a critical aspect of physician-to-patient communication, especially
among the elderly. Poor health literacy is common, and is correlated with worsening
health conditions. A major source of miscommunication is physician usage of medical
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terminology. This may be remedied by use of language at a lower reading level. One
study showed that handouts given at a fifth-grade reading level increased vaccination
rates (Williams, Davis, Parker, & Weiss, 2002). Another study of education programs for
people with chronic health problems requiring medications included three groups: one-toone counseling, group education, and one or both of these strategies in combination with
audiovisual materials. For all three groups, positive changes were observed in all
education programs (Mullen, Green, & Persinger, 1985).
Many patients, regardless of education level, have trouble understanding their
discharge instructions (Hill et al., 2016). Patients remember more information if given a
handout as opposed to just being told, and even more if it involves visual aids (Reeves &
Buescher, 2015). One study, in which standard patient discharge instructions were
compared to those that were pictograph-enhanced, found that pictographic-enhancment
improved patient recall and satisfaction with the instructions, by using measures of
immediate and delayed recall. Furthermore, patients’ understanding of their instructions
were likely increased by the addition of illustrations (Hill et al., 2016). Use of colors and
large, easy to read font in such handouts is helpful, and especially if it is in a form that
the patient can take home (Reeves & Buescher, 2015). Comics are an efficient and
effective way to communicate complex information. They have been used in science
education, as well as to promote public awareness and patient health literacy of various
ailments, including HIV. Even though comics have often been aimed only at children,
they have been successful in disseminating ideas to adults who want to learn about
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complicated ideas in fun ways. It is also helpful if the scientist is involved in both writing
and illustrating the comic (Park, Kim, & Chung, 2011).
Multiple studies (Bloch-Elkon, 2007; Catalan-Matamoros, 2011) suggest that the
mass media does indeed influence public health decisions (Adekunle & Adlan, n.d.). The
media’s power to design, package, and distribute effective messages plays an important
contributing role in combating health challenges before they become uncontrollable.
Aside from the use of comics in spreading knowledge of HIV, Adekunle and Adlan
reported that media methods were also employed in the 2014 Ebola outbreak. This was
especially noticeable in Nigeria. Stories, editorials, and images including comics and
cartoons about Ebola pervaded the Nigerian media, leading to later studies on media
framing of public health hazards. More than one third of news stories on Ebola focused
on treatment and control of the disease. This angle focused on containment of the
outbreak, as opposed to other angles that focused more on fear of death, or finding aid
after contracting the disease (Adekunle & Adland, n.d.).
In order to apply visual patient health literacy to shingles, the virus and disease
process must first be understood, beginning with the immune response to VZV. This is an
airborne virus, transmitted by cell-free virus particles (the virus floats around by itself,
unlike viruses that are contained inside cells) (Stein, Slobedman, & Abendroth, 2012).
The first cells to respond to the infection are likely dendritic cells (DCs) (Abendroth,
Morrow, Cunningham, & Slobedman, 2001). These are irregularly shaped cells that
capture antigens, which are usually proteins, at sites of contact with the external
environment, and carry the antigen until they come into contact with a T-cell specific for
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that antigen (Nairn & Helbert, 2007, p. 63). T-cells are a part of the adaptive immune
response, in which “self” is distinguished from “non-self” by recognizing foreign
substances, also called antigens (Nairn & Helbert, 2007). The two main defense cells that
recognize antigens are B cells, which secrete antibodies, and T-cells, which find antigens
presented by dendritic cells. There are two main types of T-cells: CD4+ helper cells,
which produce cytokines, and CD8+ cytotoxic cells, which kill infected cells (Nairn &
Helbert, 2007). Dendritic cells initiate responses from CD4+ and CD8+ cells, which are a
special type of T-cell that monitor the environments outside of and inside of the cell for
pathogens, respectively (Nairn & Helbert, 2007).
In VZV, dendritic cells provide a mechanism of transport of the antigens to lymph
nodes, and then to the T-cells that can become infected with the virus (although the virus
invades T-cells it does not kill them, allowing the virus to be disseminated) (Abendroth et
al., 2001). T-cells then traffic the virus to the skin (Stein et al., 2012). At the skin,
cytotoxic CD4+ and CD8+ T-cells play an important role in VZV immunity, as they
infiltrate the dermis of VZV lesions, as well as infected sensory ganglia. In response, the
immune system will deploy interferons to limit the spread of the virus and activate
natural killer cells (NKs) (Stein et al., 2012) a type of lymphocyte that kill virallyinfected cells and help activate the adaptive immune response (Nairn & Helbert, 2007).
NK cells play an important role in early VZV infection control by killing virally infected
cells before the T-cells have had a chance to clonally expand (Stein et al., 2012). Herpes
viruses such as VZV have several ways of combatting the immune response, including
preventing the infected cells from signaling that they are infected, thus inhibiting NKs
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from doing their job of killing cells. Therefore, while type 1 interferons suppress the
progress of the VZV infection, VZV in turn limits the potency of interferons (Stein et al.,
2012).
Reactivation of chickenpox virus is the primary cause of shingles. The virus stays
within the sensory ganglia for the life of the host (Stein et al., 2012). Primary infection
with VZV causes chickenpox, and subsequent reanimation of the latent virus can result in
shingles (Larkin, Heckles, & Ogilive, 1985). This was revealed by use of restriction
enzymes (which recognize specific base pair sequences of DNA and cleave the DNA
there), creating a unique restriction fragment pattern (Nairn & Helbert, 2007). Restriction
enzymes were used to compare six VZV DNA isolates, revealing that identical VZV
strains are present in the latent and reactivated states (Stein et al., 2012). For any given
restriction enzyme, VZV DNA does not show any significant variance of restriction
fragment patterns for different samples, suggesting that HZ represents the re-activation of
an original, infecting VZV strain (Picini, Ecker, Grose, & Hyman, 1983).
Herpes zoster generally develops when the previously infected individual’s
restraining immunity falls below the minimum restraining level (Thomas & Robertson,
1971). Antibodies are immunoglobulin proteins produced by B cells in response to
specific foreign antigens (such as the glycoproteins on the surface of VZV) that initially
stimulated their production (Nairn & Helbert, 2007). These glycoproteins on the surface
of the virus’ envelope are essential for viral replication and infectivity, therefore,
antibody binding to the surface proteins of VZV plays an important role in recovery from
the infection, by inhibiting cell-to-cell spread of the infection, cell killing via lymphoid
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cells, and neutralization (Larkin, Heckles & Olgive, 1985). Antibodies, then, are more
likely to prevent or limit VZV reinfection, as opposed to fighting against the virus once
the infection occurs (Stein et al., 2012). During HZ, immune cells are prone to infiltrate
the ganglia. The virus is able to penetrate abraded skin and spread up a peripheral nerve
into spinal ganglia (Thomas & Robertson, 1971). Therefore, unlike the skin infection of
chickenpox by VZV, HZ targets the peripheral nervous system (although it is already in
the nerve cells from the time of VZV infection). The reactivated virus travels to the skin
through the nerves and produces a rash very similar to that of VZV (Stein et al., 2012).
However, HZ rashes differ in that the rash is of dermatomal distribution – meaning that it
only affects one side of the body in the area of skin that is supplied by sensory neurons
originating in spinal ganglia (Centers for Disease Control, 2013). The rash mainly affects
the chest, neck, and eye areas (Centers for Disease Control, 2013). If left untreated, 50 to
70% of HZ patients develop complications of the ocular region, and in extreme cases,
blindness may occur (Centers for Disease Control, 2013).
Upon reactivation, T cells target the infected nerves. The infiltration of cells in the
spinal ganglia is composed of more CD4+ than CD8+ T-cells, but CD8+ are generally in
closer proximity to the neurons (Stein et al., 2014). CD8+ T-cells are typically responsible
for inducing the death of infected cells (Stein et al., 2012). MHC-I and MHC-II (major
histocompatibility complexes) are upregulated in human ganglia during herpes zoster
(Stein et al., 2014). This is important as herpes viruses are known to downregulate MHC
expression (Nairn & Helbert, 2007). NK cells recognize and target cells with unusual
MHC expression, so in HZ low MHC expression serves to signal NK cells to take action
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(Nairn & Helbert, 2007). Even decades after the illness, VZV-specific T-cells persist, but
over time, a decline in these T-cells - either because of time or immunosuppression leads to an increased incidence of HZ (Stein et al., 2012).
Immunity can be periodically boosted by exposure to wild-type (standard) VZV
in the community. Cell-mediated immunity (CMI), which refers to cytotoxic T-cells, or
CD8+ T-cells, decreases over time. One study found that VZV specific CMI decreased
by 2.7-3.9% each year (Levin et al., 2008). The zoster vaccine induces a significant
increase in VZV-CMI (Levin et al., 2008). The vaccine is injected into the deltoid region
(Centers for Disease Control, 2013). According to the CDC, it decreased incidence of
shingles outbreaks by 51%. Unfortunately, response to the vaccine decreases with age (by
3-4% each year) (Stein et al., 2012, Levin et al., 2008). This efficacy drops to 36.7% after
age 70 (Lal, et al, 2015). However, a new version of the vaccine that was developed
recently that contains a subunit of HZ (as opposed to live, attenuated VZV) has been
demonstrated to have 97.2% efficacy (Lal, et. al, 2015). The new vaccine does not appear
to decrease in efficacy in older adults, nor has it been recorded to induce immunemediated diseases. Another advantage of an HZ subunit vaccine is that it is less likely to
result in replication of the disease that it is supposed to prevent. This makes it a good
alternative for patients with compromised immune systems (Lal, et al, 2015).
It is imperative that aging adults are informed of the opportunity for vaccination
to help prevent shingles outbreaks before too much time has passed, and key to
accomplishing this is finding a way to disseminate HZ information effectively.
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Addressing this problem should involve asking how patients learn best, as well as how
physicians prefer to provide information.
Methods
An adult coloring book illustrating the pathophysiology of shingles was produced
for the benefit of promoting health literacy among the susceptible community. It is
intended to be an easily understood, visual reference that is designed in a take-home form
for patients. Accompanying print instructions for patient care could be available
alongside, similar to supplemental material. This could include warnings about side
affects of the vaccine, what to expect and when, and which possible side effects would
warrant a second visit to the doctor.
The target audience for the educational coloring book is the at-risk population,
although anyone could benefit from increased awareness of shingles. The coloring book
could be distributed to physicians, and made available in the waiting rooms of the office
or given directly to patients by their doctor. Patients are more likely to be vaccinated if a
healthcare provider recommends it (Teeter et al, 2014). Furthermore, it is unrealistic to
expect a nurse practitioner to cover all information related to the disease and vaccine in a
10-15 minute session (Reeves & Beuscher, 2015). The book focuses on presenting how
the virus functions in the human body and how the vaccine prevents shingles from
occurring. The design should bring to light the most important points about the disease in
such a way that a patient with little or no health literacy could grasp.
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Some images that were used in inspiration for the creative style are depicted below:

Note. “What is Blood?” by P. Wynne & D. Silver, 2009. From My First Human Body
Book, Copyright Dover Publications. Reprinted with permission.
Figure 1. The image above is an example of the relatively simple line work that makes an
effective coloring book. The lines are not completely uniform, so as not to create visual
redundancy, but the design is also not overly complex, making it easier to understand.
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Note. “Helper T Cell,” by N. Dewaswala, n.d. From Immense Immunology Insight.
Copyright N. Dewaswala. Reprinted with permission.
Figure 2. The above image is an example of the kind of anthropomorphism used in the
HZ coloring book. Anthropomorphisms make potentially frightening diseases seem less
intimidating.
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Note. “The Integumentary System,” by Education.com, n.d. From Inside-Out Anatomy.
Copyright Education.com, Inc. Reprinted with permission.

Figure 3. Images such as the one above were inspirations for cross-sectional, anatomical
level parts of the design that are inserted to help orient the viewer to a larger view of what
is happening in the picture.
Results
Based on the above inspirations, among others, the following HZ coloring book
was produced:
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I predict the outcome of this project will be threefold: (1) it will raise the vaccination rate,
thus lowering the incidence of shingles, (2) increase understanding of the mechanisms of
the virus and disease process, and (3) involve patients more thoroughly in their own
health-related decisions (as in, getting vaccines that are most beneficial to them
personally).
Discussion
An adult coloring book would provide a competitive edge over previously
existing patient education materials for several reasons. For one, adult coloring books
have recently become tremendously popular. Flett et. al. (2017) found that in 2015, they
composed 6.6% of adult nonfiction books sold for the year. Secondly, coloring has been
demonstrated as an effective stress reducer (Flett et al., 2017). A 2017 study concluded
that a weeklong coloring intervention might improve short-term depressive and anxious
symptoms (Flett et al., 2017). Dealing with illness can cause anxiety, and such a stressor
could serve to weaken the patient’s immune system at a time when it is needed most. If
coloring could reduce stress, it could be an added benefit to retention of medical
information.
The HZ vaccine is low-risk and effective. Since HZ is both common and,
unfortunately, widely misunderstood, finding new ways of spreading awareness is a
highly relevant issue to current clinical research. A coloring book would combine visual
learning with simple language in a way that would be engaging to people who might not
otherwise find interest in the topic.
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